The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 14, 2023
Filed:
May. 11, 2020
Applicant:
Teva Pharmaceuticals International Gmbh, Jona, CH;
Inventors:
Carine Claassen-Punt, Leiden, NL;
Mark Alan Smith, Elkton, MD (US);
Ling Chen, Exton, PA (US);
Ari Andrew Gershon, Petach Tikva, IL;
Assignee:
Teva Pharmaceuticals International GMBH, Jona, CH;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/16 (2006.01); A61P 25/18 (2006.01); A61K 31/551 (2006.01); A61K 31/5513 (2006.01); A61K 47/34 (2017.01); A61K 9/14 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 9/146 (2013.01); A61K 9/0019 (2013.01); A61K 9/1647 (2013.01); A61K 31/551 (2013.01); A61K 31/5513 (2013.01); A61K 47/34 (2013.01); A61P 25/18 (2018.01);
Abstract
The disclosure is directed to methods of treating schizophrenia or bipolar disorder by subcutaneously administering a sustained-release dosage form of olanzapine, or a pharmaceutically acceptable salt thereof. Methods of subcutaneously administering olanzapine, or a pharmaceutically acceptable salt thereof, are also described.